Moreover, we selected pathways closely involved in cancer progression to evaluate their activation status and revealed that mTOR signaling was enriched in cluster 1, cluster 3 highly expressed FGFR and PI3K‐AKT signaling‐related genes, while clusters 4 and 5 showed high RAF signaling pathway activity (Fig. 2E). This evidence concerns the gene MTOR and cancer.